- Home
- Applications
- europe
- blood cell
Refine by
Blood Cell Product Applications In Europe
9 applications found
An antibody deficiency is always a manifestation of the disturbed maturation or function of lymphocytes in the blood. The cells only react inadequately, if at all, to invading pathogens, and the immune system is incapable of maintaining a normal concentration of antibodies in the ...
ByBiotest AG based in Dreieich, GERMANY
We adapted an autologous ex-vivo gene therapy method to load the patient’s own TEMs precursors, that are hematopoietic stem and progenitor cells (HSPCs), with an immunotherapeutic transgene sequence. By re-introducing gene-modified HSPCs into the patient, we seek to take advantage of the self-renewing and multi-differentiation capability of HSPCs to enable durable and potentially long-term effects following a single ...
ByGenenta Science based in Milano, ITALY
Hyperbaric Oxygen Therapy (HBOT) for professional sports has become one of the most effective methods for athlete ...
ByOXYHELP INDUSTRY based in Bucuresti, ROMANIA
The development of laser technology extends back to the time around 1920 to Albert Einstein. After the first laser was constructed in 1960 the advances in laser technology developed in leaps and ...
ByHeltschl Medizintechnik GmbH based in Schlüsslberg, AUSTRIA
Traditionally, primary treatment for DVT has focused on anticoagulation, rather than thrombus removal. Anticoagulation therapy does not remove existing thrombus but rather prevents the propagation of the ...
BySurmodics, Inc. based in Eden Prairie, MINNESOTA (USA)
Immunoglobulins (antibodies) are vitally important proteins which circulate in the blood and perform a wide variety of tasks. They influence markedly the balance of our immune ...
ByBiotest AG based in Dreieich, GERMANY
The term plasmapheresis encompass different techniques (filtration or adsorption on plasma), which remove not all but only specific elements contained in the plasma, and altogether allow to treat a large number of diseases. ...
ByInfomed SA based in Meinier, SWITZERLAND
The antibody drug discovery process differs from the traditional drug discovery of small molecules as it requires the development of hybridomas and the engineering of antibodies to recognize a specific target protein. The production of recombinant antibodies in cancer treatment as well as the development of neutralizing antibodies for infectious diseases, has allowed antibody discovery platforms to interrogate the immune repertoire and develop novel antibody libraries using flow cytometry analysis and cell ...
ByNanoCellect Biomedical, Inc. based in San Diego, CALIFORNIA (USA)
Endovascular clot removal methods can provide immediate symptom relief and, by removing clot early, physicians can identify an underlying obstructive lesion that may require a stent. Current endovascular treatment methods involve catheter-directed thrombolysis (CDT), percutaneous mechanical thrombectomy (PMT), balloon venoplasty, iliac vein stenting, and manual ...
BySurmodics, Inc. based in Eden Prairie, MINNESOTA (USA)